Ray Amrit has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
Profile
Ray Amrit appears in SEC filings in connection with Ultragenyx Pharmaceutical Inc. as of May 18, 2026. The current filing context does not specify the individual's role, background, or biography. Ultragenyx Pharmaceutical is a California-based biotechnology company focused on therapies for rare genetic diseases. Based on publicly available information tied to the 2026 SEC filing, there is no widely known public profile for this name prior to the filing date.
Role
Director
Notability
25/100
Board memberships
Ultragenyx Pharmaceutical Inc.
Awards & honors
No publicly documented achievements in SEC filings as of 2026-05-18.
Ray Amrit appears in SEC filings in connection with Ultragenyx Pharmaceutical Inc. as of May 18, 2026. The current filing context does not specify the individual's role, background, or biography. Ultragenyx Pharmaceutical is a California-based biotechnology company focused on therapies for rare genetic diseases. Based on publicly available information tied to the 2026 SEC filin…
How many SEC Form 4 filings has Ray Amrit submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Ray Amrit's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
